Quick Answer
ELITE PHARMACEUTICALS INC /NV/ reported Shares Outstanding of 1.07 billion shares for fiscal year 2025.
ELITE PHARMACEUTICALS INC /NV/ Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 1.07B | +0.0% |
| 2024 | 1.07B | +5.4% |
| 2023 | 1.01B | +0.3% |
| 2022 | 1.01B | +0.2% |
| 2021 | 1.01B | +20.1% |
| 2020 | 840.40M | +1.9% |
| 2019 | 824.85M | +2.8% |
| 2018 | 802.53M | -13.5% |
| 2017 | 927.93M | +30.4% |
| 2016 | 711.44M | +12.7% |
| 2015 | 631.06M | +12.7% |
| 2014 | 560.14M | +49.6% |
| 2013 | 374.39M | +12.9% |
| 2012 | 331.65M | +83.7% |
| 2011 | 180.55M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | 1.07B | +0.6% | +0.1% |
| September 30, 2025 | 1.07B | +0.5% | +0.5% |
| June 30, 2025 | 1.07B | +0.0% | +0.0% |
| March 31, 2025 | 1.07B | +0.0% | +0.0% |
| December 31, 2024 | 1.07B | +5.0% | +0.0% |
| September 30, 2024 | 1.07B | +5.4% | +0.0% |
| June 30, 2024 | 1.07B | +5.4% | +0.0% |
| March 31, 2024 | 1.07B | +5.4% | +5.0% |
- ELITE PHARMACEUTICALS INC /NV/ showed an increase of +0.0% in Shares Outstanding compared to the prior fiscal year.
- Over the 2011–2025 period, ELITE PHARMACEUTICALS INC /NV/’s shares outstanding has grown by 491.7% (from 180.55 million shares to 1.07 billion shares).
- The most recent figure is from ELITE PHARMACEUTICALS INC /NV/’s fiscal year 2024 report (Form 10-K), filed with the SEC on June 30, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: